Literature DB >> 16620961

Georg Schmorl on trophoblasts in the maternal circulation.

O Lapaire1, W Holzgreve, J C Oosterwijk, R Brinkhaus, D W Bianchi.   

Abstract

Trafficking of cells between the fetus and its mother provides indirect clues to the underlying pathophysiology of pregnancy. Georg Schmorl first documented the presence of fetal cells in the maternal body and emphasized the importance of the placenta in eclampsia. Although his classic paper, written in 1893, is widely cited today, few investigators have actually read the paper, as it was published in German [Schmorl G., Pathologisch-anatomische Untersuchungen über Puerperal-Eklampsie. Verlag FCW Vogel, Leipzig; 1893]. Our goal was to translate the paper into English and critically re-evaluate its conclusions from a 21st century perspective. Schmorl was remarkably astute in his assessment of the pathologic changes that were seen in the 17 women on whom he performed complete autopsies. He found similar severe changes in all of the women, implying a common pathogenesis. This was in direct contrast to the then current doctrine. He was the first to observe the presence of thrombi containing multinucleated syncytial giant cells in the lungs of the women and speculated that they were of placental origin. To support his hypothesis he performed animal experiments. He also recognized that feto-maternal trafficking occurred in normal gestations but was increased in pregnancies affected by eclampsia. Using sophisticated molecular techniques we can now precisely confirm what Schmorl so elegantly described.

Entities:  

Mesh:

Year:  2006        PMID: 16620961     DOI: 10.1016/j.placenta.2006.02.004

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  30 in total

Review 1.  Molecular Mechanisms of Preeclampsia.

Authors:  Tammy Hod; Ana Sofia Cerdeira; S Ananth Karumanchi
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-20       Impact factor: 6.915

Review 2.  Placental extracellular vesicles and feto-maternal communication.

Authors:  M Tong; L W Chamley
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-29       Impact factor: 6.915

3.  Maternal serum proteome changes between the first and third trimester of pregnancy in rural southern Nepal.

Authors:  P F Scholl; R N Cole; I Ruczinski; M Gucek; R Diez; A Rennie; C Nathasingh; K Schulze; P Christian; J D Yager; J D Groopman; K P West
Journal:  Placenta       Date:  2012-03-03       Impact factor: 3.481

Review 4.  Maternal-fetal cellular trafficking: clinical implications and consequences.

Authors:  Cerine Jeanty; S Christopher Derderian; Tippi C Mackenzie
Journal:  Curr Opin Pediatr       Date:  2014-06       Impact factor: 2.856

5.  Vitamin D Reduces Oxidative Stress-Induced Procaspase-3/ROCK1 Activation and MP Release by Placental Trophoblasts.

Authors:  Jie Xu; Xiuyue Jia; Yang Gu; David F Lewis; Xin Gu; Yuping Wang
Journal:  J Clin Endocrinol Metab       Date:  2017-06-01       Impact factor: 5.958

Review 6.  Prediction of preeclampsia-bench to bedside.

Authors:  Anjali Acharya; Wunnie Brima; Shivakanth Burugu; Tanvi Rege
Journal:  Curr Hypertens Rep       Date:  2014-11       Impact factor: 5.369

Review 7.  Naturally acquired microchimerism.

Authors:  Hilary S Gammill; J Lee Nelson
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

Review 8.  Cell migration from baby to mother.

Authors:  Gavin S Dawe; Xiao Wei Tan; Zhi-Cheng Xiao
Journal:  Cell Adh Migr       Date:  2007-01-28       Impact factor: 3.405

9.  Cellular fetal microchimerism in preeclampsia.

Authors:  Hilary S Gammill; Tessa M Aydelotte; Katherine A Guthrie; Evangelyn C Nkwopara; J Lee Nelson
Journal:  Hypertension       Date:  2013-10-07       Impact factor: 10.190

Review 10.  Noninvasive fetal genome sequencing: a primer.

Authors:  Matthew W Snyder; LaVone E Simmons; Jacob O Kitzman; Donna A Santillan; Mark K Santillan; Hilary S Gammill; Jay Shendure
Journal:  Prenat Diagn       Date:  2013-04-01       Impact factor: 3.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.